open🌐 Maryland2710437377

Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living

Summary?

Maryland has posted an open government solicitation: Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living. Responses are due July 30, 2026.

Details?

Posted: Jul 22, 2026
Response deadline: Jul 30, 2026, 11:59 PM UTC (6d)
Status: open
Jurisdiction: Maryland
Reference #: 2710437377
Has Description: false

Closing: 07/30/2026
Published: 07/22/2026

Similar past solicitations

Behavioral Health Substance Use Disorder Residential Treatment Providers
County of San Benito · Mar 10, 2026
Improving Mental Health and Engagement in Care Among People with HIV — Implementation Technical Assistance Provider
United States · Jan 16, 2025
Improving Mental Health and Engagement in Care Among People with HIV — Evaluation Provider
United States · Jan 16, 2025
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP)
United States · Apr 12, 2023
Emerging Strategies to Improve Health Outcomes for People Aging with HIV: Demonstration Sites
United States · Oct 26, 2021
BJA FY24 Improving Substance Use Disorder Treatment and Recovery Outcomes for Adults in Reentry
United States · Mar 11, 2024

Finding similar opportunities…

This listing is a summary from Maryland's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.